BiomX
PHGE
10 hedge funds and large institutions have $2.46M invested in BiomX in 2022 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 2 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
0.01% less ownership
Funds ownership: 0.12% → 0.11% (-0.01%)
17% less funds holding
Funds holding: 12 → 10 (-2)
81% less capital invested
Capital invested by funds: $12.8M → $2.46M (-$10.3M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$19.7K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$9.86K |
| 3 |
RA
Royce & Associates
New York
|
+$8.62K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KC
Kepos Capital
New York
|
-$870K |
| 2 |
Millennium Management
New York
|
-$19.9K |
| 3 |
Jane Street
New York
|
-$2.67K |
| 4 |
JP Morgan Chase
New York
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
JJ
1
Johnson & Johnson
New Brunswick,
New Jersey
| $1.56M | – | – | – |
|
|
MI
2
MMCAP International
Grand Cayman,
Cayman Islands
| $500K | – | – | – |
|
|
RA
3
Royce & Associates
New York
| $240K | +$8.62K | +42 | +2% |
|
|
4
Millennium Management
New York
| $58K | -$19.9K | -97 | -19% |
|
|
BCM
5
Bridgeway Capital Management
Houston,
Texas
| $43K | – | – | – |
|
|
6
Renaissance Technologies
New York
| $31K | +$19.7K | +96 | +76% |
|
|
7
Jane Street
New York
| $16K | -$2.67K | -13 | -10% |
|
|
8
UBS Group
Zurich,
Switzerland
| $8K | +$9.86K | +48 | +600% |
|
9
BlackRock
New York
| $4K | – | – | – |
|
|
O
10
OrbiMed
New York
| $2.05K | – | – | – |
|
|
KC
11
Kepos Capital
New York
| – | -$870K | -2,372 | Closed |
|
|
12
JP Morgan Chase
New York
| – | -$1K | -3 | Closed |
|
PHGE Hedge Fund Activity: Q2 2022 in Review
10 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in BiomX (PHGE) for Q2 2022, worth a combined $2.46M — down 81% from $12.8M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of PHGE and 0 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 3 added.
The largest buyer was Renaissance Technologies, adding an estimated $19.7K. The largest seller was Kepos Capital, exiting entirely with an estimated $870K sold.
- 10 institutional investors held BiomX (PHGE) as of Q2 2022, down from 12 in Q1 2022.
- Funds reported $2.46M of BiomX stock for Q2 2022, down 81% quarter-over-quarter.
- 0 funds opened new BiomX positions in Q2 2022 and 2 closed out, a net change of -2 holders.
- The largest BiomX buyer in Q2 2022 was Renaissance Technologies, an estimated $19.7K added.
- The largest BiomX seller in Q2 2022 was Kepos Capital, an estimated $870K sold.
Based on aggregated 13F filings for Q2 2022.